| ¿µ¹® | myasthenia gravis | ÇÑ±Û | ÁßÁõ±ÙÀ°¹«·ÂÁõ |
|---|---|---|---|
| ¼³¸í | Ȱµ¿½Ã¿¡ ±Ù´ë¾à°ú ÇǷθ¦ È£¼ÒÇÏ´Ù°¡ ¾ÈÁ¤ ÈÄ¿¡´Â ȸº¹µÇ´Â Ư¡ÀûÀÎ Áõ»óÀ» È£¼ÒÇÏ´Â º´À¸·Î, ±ÙÀ°°ú ½Å°æÁ¢ÇպΠ»çÀÌ ¿¬°áºÎºÐ ÀÌ»óÀ¸·Î ¹ß»ýÇÑ´Ù. ÁÖ·Î ÀþÀº ¿©¼º¿¡¼ ºó¹ßÇϰí, ´«ÁÖÀ§ ±ÙÀ°À» Àß Ä§¹üÇÑ´Ù. ´ë°³ ¾ÆÄ§À̳ª ÈÞ½Ä ÈÄ¿¡´Â È£ÀüµÇ¾ú´Ù°¡ ¿îµ¿½Ã ¾ÇȵǴ ÇÇ·ÎÇö»óÀ» º¸ÀδÙ. ¸ÞÄ¿´ÏÁòÀº ¾Æ¸¶ ¸é¿ª°èÀÇ ÀÌ»óÀ¸·Î ÀÎÇØ ¹ß»ýÇÏ´Â °ÍÀ¸·Î º¸À̸ç, Ä¡·á ¶ÇÇÑ ¸é¿ªÀ» ¾ïÁ¦ÇÏ´Â ¾àÀ» ´Ù·® Åõ¿©ÇÔÀ¸·Î½á È£ÀüµÇ¾ú´Ù´Â º¸°í°¡ ¸¹´Ù. ħ¹üºÎÀ§ÀÇ ±ÙÀ°¿¡ µû¶ó ¿©·¯ °¡Áö Á¾·ù°¡ ÀÖÀ¸¸ç, È£Èí±Ù±îÁö ħ¹üÇÏ°Ô µÇ¸é, È£Èí±â´É»ó½Ç·Î »ç¸ÁÇÑ´Ù. ½Å°æ-±ÙÀ° Á¢ÇպΠÁß Á¢ÇÕµÚ¸·ÀÇ ¾Æ¼¼Æ¿Äݸ° ¼ö¿ëüÀÇ Àå¾Ö°¡ ¹ß»ýÇÏ´Â ÀÚ°¡¸é¿ªº´ÀÌ´Ù. µû¶ó¼ ½Å°æ-±ÙÀ° Á¢Çպο¡¼ ½Å°æÀÚ±Ø Àü´ÞÀÌ Â÷´ÜµÇ¾î ±ÙÀ°¼è¾à°ú Á¶±â ÇǷΰ¡ ¿Â´Ù. ȯÀÚÀÇ 85~90%¿¡¼ Ç÷Áß¿¡ ¾Æ¼¼Æ¿Äݸ° ¼ö¿ëü¿¡ ´ëÇÑ Ç×ü°¡ ÀÖ´Ù. ÀüÀÚÇö¹Ì°æÀ¸·Î °üÂû½Ã ½Å°æ ±ÙÀ° Á¢ÇպΠÁ¢ÇÕÁÖ¸§ °¨¼Ò ¹× ´Ü¼øÈ¸¦ º¸ÀδÙ. ȯÀÚÀÇ 15~50%´Â °¡½¿»ùÁ¾°ú µ¿¹ÝµÇ°í ³ª¸ÓÁö´Â °¡½¿»ù°ú´ÙÇü¼º°ú Àß µ¿¹ÝµÈ´Ù. ±¤ÇÐÇö¹Ì°æ»ó¿¡¼´Â 2Çü ±ÙÀ°¼¶À¯ÀÇ À§Ãà°ú Å»½Å°æ¿¡ ÀÇÇÑ ÀÛ°í °¢Áø ±ÙÀ°¼¶À¯°¡ ³ªÅ¸³ª´Â °Í À̿ܿ¡´Â Ưº°ÇÑ ¼Ò°ßÀ» º¸ÀÌÁö ¾Ê´Â´Ù. |
||
| ¿µ¹® | Dilatation and Curettage(D & C) | ÇÑ±Û | Àڱñܾ¼ú, ÀڱøñÈ®Àå |
|---|---|---|---|
| ¼³¸í | ÀÚ±ÃÀ̶õ žư¡ ¼öÅÂµÇ¾î¼ ºÐ¸¸Àü±îÁö ¹ßÀ°ÇÏ°í ¼ºÀåÇÏ´Â °ø°£ÀÌ´Ù. Àڱüӿ¡ º´º¯ÀÌ ÀÖ¾î ÀÓ½ÅÀÌ °è¼ÓµÉ ¼ö ¾ø°Å³ª ¾Æ´Ï¸é ´Ù¸¥ ÀÌÀ¯·Î ÀӽŵǾî Àִ žƸ¦ Á¦°ÅÇϰíÀÚ ÇÒ °æ¿ì¿¡ »ç¿ëµÇ´Â ¹æ¹ýÀÌ´Ù. ¿©±â¼ ±Ü¾î³»±â À§ÇÏ¿©´Â ¿ì¼± ÀÚ±ÃÀÇ ÀÔ±¸¿¡ ÇØ´çÇÏ´Â ÀڱøñÀ» È®Àå½ÃÄÑ¾ß ÇÑ´Ù. ¿©±â¿¡´Â ±Þ¼ÓÈ÷ È®ÀåÀ» ½ÃµµÇÏ´Â ¹ý°ú ¼¼È÷ È®ÀåÀ» ½ÃµµÇÏ´Â 2°¡Áö ¹æ¹ýÀÌ ÀÖ´Ù. ÀڱøñÀ» ±Þ¼ÓÈ÷ È®ÀåÇÒ ¶§´Â Çì°¡¸£ ¸ñ°üÈ®Àå±â(Hegar's dilatator)¸¦ »ç¿ëÇÑ´Ù. À̰ÍÀº ÀÛÀº ±Ý¼Ó¸·´ë·Î ÀÛÀº Å©±âºÎÅÍ Å« Å©±â±îÁö ´Ù¾çÇÑ Å©±â°¡ ÀÖ¾î¼ ¿ì¼± ÀÛÀº ¸·´ë·Î ½ÃÀÛÇÏ¿© Á¡Á¡ Å« Å©±âÀÇ ¸·´ë¸¦ Àڱøñ¿¡ ³Ö¾î¼ ÀڱøñÀ» È®Àå½ÃŲ´Ù. ¼¼È÷ È®Àå½Ãų ¶§´Â Laminaria tent¸¦ ¸ñ°ü¿¡ »ðÀÔÇÏ´Â ¹æ¹ýÀ» »ç¿ëÇÑ´Ù. Laminaria tent¶õ ÇØÃÊ·Î ¸¸µç ÀÛÀº ¸·´ë·Î ¼öºÐÀ» Èí¼öÇϸé Á¡Á¡ ´Ã¾î³ª´Â ¼ºÁúÀÌ ÀÖ´Ù. À̰ÍÀ» ÀÚ±ÃÀÇ ¸ñ¿¡ ³ÖÀ¸¸é À̰ÍÀÌ ¼öºÐÀ» Èí¼öÇÏ¿© ´Ã¾î³ª¹Ç·Î õõÈ÷ ÀÚ±ÃÀÇ ¸ñÀÌ ´Ã¾î³´Ù. ÀڱøñÀÌ ÃæºÐÈ÷ ´Ã¾î³ª¸é ±× ¼ÓÀ¸·Î ³¡ÀÌ ¼ù°¡¶ôó·³ »ý±ä ±â±¸¸¦ ³Ö¾î¼ ÀڱüÓÀÇ º´º¯À̳ª ÀÓ½ÅµÈ Å¾Ƹ¦ ±Ü¾î³»´Âµ¥ ¿©±â¿¡ »ç¿ëµÇ´Â ¼ù°¡¶ôó·³ »ý±ä ±â±¸¸¦ Å¥·¿À̶ó°í ÇÑ´Ù. Ãʱâ ÀÓ½ÅÁßÀý Áï À¯»ê°ú °°Àº ÀӽŰú °ü·ÃµÈ °æ¿ì»Ó¸¸ ¾Æ´Ï¶ó, ºñÀӽŠÀÚ±ÃÀÇ Àڱ󻸷Á¶Á÷ÀÇ Ã¤Ãë ¹× Á¦°Å¸¦ À§Çؼµµ ÇàÇØÁö´Â ¼ö±âÀÌ´Ù. ÀÌ´Â ¿øÄ¢ÀûÀ¸·Î ¸¶ÃëÇÏ¿¡ ½Ç½ÃµÇ´Â °ÍÀ¸·Î Àڱøñ°üÀ» È®ÀåÇÏ°í ±â±¸·Î Àڱà ³»¿ë¹°À» Á¦°ÅÇϰí Å¥·¿À¸·Î Àڱ󻺮À» ±ú²ýÀÌ ÇÑ´Ù. ÀÚ±Ãõ°øÀ̳ª ÀڱøñÀÇ ÆÄ¿ µîÀÇ À§ÇèÀÌ µû¸£¸ç, ¼ö¼úÈÄ °¨¿° ¶Ç´Â ÃâÇ÷ µî¿¡ ´ëÇÑ ÁÖÀǰ¡ ÇÊ¿äÇÏ´Ù. |
||
| MG | 1) Myasthenia Gravis 2) MonoGlyceride 3) Monoclonal Gammop... |
|---|---|
| CMG | canine or congenital myasthenia gravis; chopped meat glucose [medium]; cystometrography, cystometrog... |
| EAMG | experimental autoimmune myasthenia gravis |
| FIMG | familial infantile myasthenia gravis |
| JAMG | juvenile autoimmune myasthenia gravis |
| EAMG | Experimental Autoimmune Myasthenia Gravis |
|---|---|
| MG | MYASTHENIA GRAVIS |
| ACCESS | Access to Community Care and Effective Services and Support |
| EPSDT | Early and Periodic Screening Diagnosis and Treatment |
acute angle
| myasthenia gravis and thymoma | <radiology> Of patients with MG 15% have thymoma, of patients with thymoma 50% have MG (12 Dec 1998) |
|---|
| myasthenia gravis | <disease, neurology> The characteristic feature of the disease is easy fatigue of certain voluntary muscle groups on repeated use. Muscles of the face or upper trunk are especially likely to be affected. In most and perhaps all cases due to the development of autoantibodies against the acetylcholine receptor in neuromuscular junctions. Immunisation of mice or rats with this receptor protein leads to a disease with the features of myasthenia. (18 Nov 1997) |
|---|---|
| thymoma | <oncology, tumour> A tumour of thymic origin. (18 Nov 1997) |
| myasthenia | <anatomy, neurology> Muscular debility, any constitutional anomaly of muscle. Origin: Gr. Astheneia = weakness (18 Nov 1997) |
| myasthenia angiosclerotica | <symptom> A symptom complex characterised by leg pain and weakness brought on by walking, with the disappearance of the symptoms following a brief rest. (12 Dec 1998) |
| anaemia gravis | <haematology> This form of anaemia occurs when the bone marrow ceases sufficient red and white blood cell production. It may be induced by exposures to high levels of toxic chemicals, radiation and certain drugs. It is generally unresponsive to specific therapy, often accompanied by granulocytopenia and thrombocytopenia, in which the bone marrow may not necessarily be hypocellular or hypoplastic but fails to produce adequate numbers of peripheral blood elements. The term actually is all inclusive and most probably encompasses several clinical syndromes. Origin: Gr. Haima = blood (29 Sep 1997) |
| colitis gravis | An obsolete term for ulcerative colitis. (05 Mar 2000) |
| neurasthenia gravis | A condition of extreme and lasting neurasthenia. (05 Mar 2000) |
| icterus gravis | Jaundice associated with high fever and delirium; seen in severe hepatitis and other diseases of the liver with severe functional failure. Synonym: malignant jaundice. (05 Mar 2000) |
| oneirodynia gravis | 1. A fiend or incubus formerly supposed to cause trouble in sleep. 2. A condition in sleep usually caused by improper eating or by digestive or nervous troubles, and characterised by a sense of extreme uneasiness or discomfort (as of weight on the chest or stomach, impossibility of motion or speech, etc), or by frightful or oppressive dreams, from which one wakes after extreme anxiety, in a troubled state of mind; incubus. 3. Hence, any overwhelming, oppressive, or stupefying influence. Origin: Night + mare incubus. See Mare incubus. Source: Websters Dictionary (01 Mar 1998) |
| abstracting and indexing | Shortening or summarizing of documents; assigning of descriptors for referencing documents. (12 Dec 1998) |
| academies and institutes | Organizations representing specialised fields which are accepted as authoritative; may be non-governmental, university or an independent research organization, e.g., national academy of sciences, brookings institution, etc. (12 Dec 1998) |
| accounts payable and receivable | Short-term debt obligations and assets occurring in the regular course of operational transactions. (12 Dec 1998) |
| aged, 80 and over | A person 80 years of age and older. (12 Dec 1998) |
| algae and fungi | Algae represent a group of spore-propagating plants, unicellular or undifferentiated into root, stem, and leaf. They include seaweed and many unicellular fresh water plants, most of which contain chlorophyll. They account for about 90% of the earth's photosynthetic activity. Fungi are eukaryotic, heterotrophic organisms that live as saprobes or parasites and include mushrooms, yeasts, smuts, molds, etc. They lack chlorophyll. (12 Dec 1998) |
| alkyl and aryl transferases | <enzyme> A somewhat heterogeneous class of enzymes that catalyze the transfer of alkyl or related groups (excluding methyl groups). Registry number: EC 2.5 (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|